CYCLERION THERAPEUTICS, INC. (KRSA) Total assets 2019–2025
CYCLERION THERAPEUTICS, INC. (KRSA) total assets at each fiscal year-end, per SEC filings.
$10.0MFY2025 · since FY2019: $186.5M → $10.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $10.0M | +4.3% |
| FY2024 | $9.6M | -28.4% |
| FY2023 | $13.4M | -26.0% |
| FY2022 | $18.1M | -69.5% |
| FY2021 | $59.3M | -48.6% |
| FY2020 | $115.4M | -38.1% |
| FY2019 | $186.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More KRSA financial trends
KRSA RevenueKRSA Net incomeKRSA Net marginKRSA Gross profitKRSA Gross marginKRSA Operating incomeKRSA Operating marginKRSA Operating cash flowKRSA Free cash flowKRSA Capital expendituresKRSA Return on equityKRSA Stock buybacksKRSA Dividends paidKRSA Total liabilitiesKRSA Shareholders’ equityKRSA overview →